Metric Deep Dive: Understanding Viridian Therapeutics Inc (VRDN) Through its Ratios

In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.

After finishing at $13.90 in the prior trading day, Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $14.34, up 3.17%. In other words, the price has increased by $3.17 from its previous closing price. On the day, 0.62 million shares were traded. VRDN stock price reached its highest trading level at $14.71 during the session, while it also had its lowest trading level at $13.93.

Ratios:

Our goal is to gain a better understanding of VRDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.26 and its Current Ratio is at 18.26. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.04.

On May 09, 2024, B. Riley Securities Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $25 to $20.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 22 ’24 when Fairmount Funds Management LLC bought 476,190 shares for $21.00 per share. The transaction valued at 9,999,990 led to the insider holds 1,839,954 shares of the business.

Meisner Lara sold 27 shares of VRDN for $765 on Jun 16 ’23. The Chief Legal Officer now owns 29,971 shares after completing the transaction at $28.35 per share. On Jun 15 ’23, another insider, Meisner Lara, who serves as the Chief Legal Officer of the company, sold 2,269 shares for $28.02 each. As a result, the insider received 63,577 and left with 29,971 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 915214656 and an Enterprise Value of 523693184. For the stock, the TTM Price-to-Sale (P/S) ratio is 3155.79 while its Price-to-Book (P/B) ratio in mrq is 3.29. Its current Enterprise Value per Revenue stands at 1818.379 whereas that against EBITDA is -2.207.

Stock Price History:

Over the past 52 weeks, VRDN has reached a high of $28.35, while it has fallen to a 52-week low of $10.93. The 50-Day Moving Average of the stock is -11.98%, while the 200-Day Moving Average is calculated to be -17.12%.

Shares Statistics:

The stock has traded on average 919.23K shares per day over the past 3-months and 896750 shares per day over the last 10 days, according to various share statistics. A total of 63.82M shares are outstanding, with a floating share count of 56.79M. Insiders hold about 11.02% of the company’s shares, while institutions hold 91.17% stake in the company. Shares short for VRDN as of 1714435200 were 9313837 with a Short Ratio of 10.13, compared to 1711584000 on 9471425. Therefore, it implies a Short% of Shares Outstanding of 9313837 and a Short% of Float of 17.14.

Most Popular

[the_ad id="945"]